Timing of Surgical Intervention After Percutaneous Catheter Drainage in STEP UP Approach for Severe Acute Pancreatitis
1 other identifier
interventional
40
1 country
2
Brief Summary
- 1.To determine the appropriate timing of surgical intervention after Percutaneous Catheter Drainage (PCD) in infected pancreatic necrosis (IPN).
- 2.To see the change in morbidity and mortality after changing the interval of surgery after PCD
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2011
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 21, 2012
CompletedFirst Posted
Study publicly available on registry
February 6, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedNovember 11, 2014
November 1, 2014
1.4 years
January 21, 2012
November 8, 2014
Conditions
Outcome Measures
Primary Outcomes (4)
Mortality
participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks
Reversal of existing organ failure
participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks
New onset multiorgan failure or sepsis and systemic complications
participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks
Locoregional complications
Pseudocyst, Pancreatic fistula, Enteric fistula, Perforation of a hollow viscus, and bleeding requiring intervention
participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks
Secondary Outcomes (3)
Proportion of patients in which surgery would be avoided in Group B
participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks
Pancreatic insufficiency (New onset Diabetes and steatorrhea)
participants will be followed for the duration of hospital discharge to end of our study period, an expected average duration of 1 year
Total number of PCD catheters and catheter related interventions required, and catheter and drain related complications
participants will be followed for the duration of hospital stay, an expected average duration of 5 weeks
Study Arms (2)
Group A
OTHERundergo surgery between days 10 - 15 after PCD
Group B
OTHERcontinued with PCD beyond 15 days and indications for surgery in them will be, 1. Persistent sepsis or symptoms 2. Worsening of clinical condition 3. Failure to thrive 4. Complications of SAP or PCD
Interventions
Patients who are not improving by day 10 after PCD insertion will be included in the present study and are randomized to group A (early surgery i.e. between 10-15days after PCD insertion ) or group B (Extended treatment with PCD with saline irrigation for more than 15days after PCD insertion)
Eligibility Criteria
You may qualify if:
- All patients with diagnosis of IPN (UK GUIDELINES) managed with percutaneous catheter drainage (PCD) for 10 to 15 days and not showing significant improvement on PCD will be included
You may not qualify if:
- Patient showing significant improvement on PCD within 10 days of its insertion.(Significant improvement on PCD is defined as resolution of fever, acceptance of enteral nutrition, decrease in total leukocyte count, reversal of organ system failure)
- Sterile pancreatic necrosis
- An acute intra abdominal event ( perforation of hollow viscus, bleeding, or the abdominal compartment syndrome) during or within 10 days after PCD insertion
- Previous drainage or surgical necrosectomy for infected pancreatic necrosis (ERCP with or without papillotomy is allowed.)
- Previous exploratory laparotomy for acute abdomen and diagnosis of pancreatitis during laparotomy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
PGIMER
Chandigarh, Chandigarh, 160012, India
Postgraduate Institute of Medical Education and Research
Chandigarh, 160012, India
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Rajesh Gupta, MBBS,MS, MCh
Post Graduate Institute of Medical Education and Research, Chandigarh
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 21, 2012
First Posted
February 6, 2012
Study Start
July 1, 2011
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
November 11, 2014
Record last verified: 2014-11